Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease

Journal of Neuroinflammation  (2023) 20 (1), 147 DOI: 10.1186/s12974-023-02830-w